Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...
Hosted on MSN3mon
Kymera's IND Application for STAT6 Degrader Gets FDA ClearanceSanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... highly selective and heterobifunctional small molecule degrader of STAT3. The candidate demonstrated antitumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results